Literature DB >> 23217423

A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network.

Azadeh Golipour1, Laurent David, Yu Liu, Gowtham Jayakumaran, Calley L Hirsch, Dan Trcka, Jeffrey L Wrana.   

Abstract

Reprogramming of somatic cells to a pluripotent state via expression of Oct4, Klf4, Myc, and Sox2 is a multistep process involving phased changes in gene expression. Here, we focus on the later stages of reprogramming, termed maturation and stabilization. We show that the stabilization phase and the acquisition of pluripotency are dependent on the removal of transgene expression late in the maturation phase. Clonal analysis of cells undergoing reprogramming revealed subsets of stabilization-competent (SC) and stabilization-incompetent (SI) cells. SC clones acquire a competency gene-expression signature late in the maturation phase. Functional analysis of SC signature genes identified enhancers of the transition to the stabilization phase and a distinct subset of genes required for the maintenance of pluripotency. Thus, the acquisition and maintenance of pluripotency are regulated by distinct molecular networks, and a specific regulatory program not previously implicated in reprogramming is required for the transition to transgene independence.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23217423     DOI: 10.1016/j.stem.2012.11.008

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  79 in total

Review 1.  Molecular features of cellular reprogramming and development.

Authors:  Zachary D Smith; Camille Sindhu; Alexander Meissner
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-17       Impact factor: 94.444

Review 2.  Toward pluripotency by reprogramming: mechanisms and application.

Authors:  Tao Wang; Stephen T Warren; Peng Jin
Journal:  Protein Cell       Date:  2013-11       Impact factor: 14.870

3.  Identification of Ccr4-not complex components as regulators of transition from partial to genuine induced pluripotent stem cells.

Authors:  Masayoshi Kamon; Miyuki Katano; Keiko Hiraki-Kamon; Tomoaki Hishida; Yutaka Nakachi; Yosuke Mizuno; Yasushi Okazaki; Ayumu Suzuki; Masataka Hirasaki; Atsushi Ueda; Masazumi Nishimoto; Hidemasa Kato; Akihiko Okuda
Journal:  Stem Cells Dev       Date:  2013-12-09       Impact factor: 3.272

Review 4.  Autophagy and cell reprogramming.

Authors:  Shuo Wang; Pengyan Xia; Markus Rehm; Zusen Fan
Journal:  Cell Mol Life Sci       Date:  2015-01-09       Impact factor: 9.261

5.  Genome-wide characterization of the routes to pluripotency.

Authors:  Samer M I Hussein; Mira C Puri; Peter D Tonge; Marco Benevento; Andrew J Corso; Jennifer L Clancy; Rowland Mosbergen; Mira Li; Dong-Sung Lee; Nicole Cloonan; David L A Wood; Javier Munoz; Robert Middleton; Othmar Korn; Hardip R Patel; Carl A White; Jong-Yeon Shin; Maely E Gauthier; Kim-Anh Lê Cao; Jong-Il Kim; Jessica C Mar; Nika Shakiba; William Ritchie; John E J Rasko; Sean M Grimmond; Peter W Zandstra; Christine A Wells; Thomas Preiss; Jeong-Sun Seo; Albert J R Heck; Ian M Rogers; Andras Nagy
Journal:  Nature       Date:  2014-12-11       Impact factor: 49.962

Review 6.  Cell signalling pathways underlying induced pluripotent stem cell reprogramming.

Authors:  Kate Hawkins; Shona Joy; Tristan McKay
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

Review 7.  Small molecules for reprogramming and transdifferentiation.

Authors:  Hua Qin; Andong Zhao; Xiaobing Fu
Journal:  Cell Mol Life Sci       Date:  2017-07-11       Impact factor: 9.261

Review 8.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

Review 9.  Epigenetics of reprogramming to induced pluripotency.

Authors:  Bernadett Papp; Kathrin Plath
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

10.  AP-1 activity is a major barrier of human somatic cell reprogramming.

Authors:  Yuting Liu; Jiangping He; Ruhai Chen; He Liu; Jocelyn Chen; Yujian Liu; Bo Wang; Lin Guo; Duanqing Pei; Jie Wang; Jing Liu; Jiekai Chen
Journal:  Cell Mol Life Sci       Date:  2021-06-28       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.